U.S. Markets open in 51 mins
  • S&P Futures

    4,119.75
    -6.75 (-0.16%)
     
  • Dow Futures

    33,669.00
    -34.00 (-0.10%)
     
  • Nasdaq Futures

    13,741.50
    -52.75 (-0.38%)
     
  • Russell 2000 Futures

    2,185.10
    +1.10 (+0.05%)
     
  • Crude Oil

    61.27
    -1.40 (-2.23%)
     
  • Gold

    1,785.20
    +6.80 (+0.38%)
     
  • Silver

    26.17
    +0.33 (+1.26%)
     
  • EUR/USD

    1.2009
    -0.0032 (-0.2642%)
     
  • 10-Yr Bond

    1.5700
    +0.0080 (+0.51%)
     
  • Vix

    18.62
    +1.33 (+7.69%)
     
  • GBP/USD

    1.3914
    -0.0023 (-0.1642%)
     
  • USD/JPY

    108.0100
    -0.0600 (-0.0555%)
     
  • BTC-USD

    55,268.21
    -570.54 (-1.02%)
     
  • CMC Crypto 200

    1,267.63
    +33.21 (+2.69%)
     
  • FTSE 100

    6,875.60
    +15.73 (+0.23%)
     
  • Nikkei 225

    28,508.55
    -591.83 (-2.03%)
     

Estimating The Intrinsic Value Of Sharps Compliance Corp. (NASDAQ:SMED)

  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·6 min read
  • Oops!
    Something went wrong.
    Please try again later.

How far off is Sharps Compliance Corp. (NASDAQ:SMED) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to their present value. I will be using the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward.

Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

Check out our latest analysis for Sharps Compliance

What's the estimated valuation?

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate:

10-year free cash flow (FCF) estimate

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Levered FCF ($, Millions)

-US$1.1m

US$1.30m

US$3.10m

US$3.60m

US$4.80m

US$5.71m

US$6.51m

US$7.19m

US$7.77m

US$8.25m

Growth Rate Estimate Source

Analyst x1

Analyst x1

Analyst x1

Analyst x1

Analyst x1

Est @ 19.03%

Est @ 13.98%

Est @ 10.46%

Est @ 7.98%

Est @ 6.26%

Present Value ($, Millions) Discounted @ 7.0%

-US$1.0

US$1.1

US$2.5

US$2.7

US$3.4

US$3.8

US$4.0

US$4.2

US$4.2

US$4.2

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = US$29m

The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 10-year government bond rate (2.2%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 7.0%.

Terminal Value (TV)= FCF2029 × (1 + g) ÷ (r – g) = US$8.3m× (1 + 2.2%) ÷ 7.0%– 2.2%) = US$175m

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$175m÷ ( 1 + 7.0%)10= US$89m

The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$118m. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of US$6.8, the company appears about fair value at a 6.0% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.

NasdaqCM:SMED Intrinsic value May 21st 2020
NasdaqCM:SMED Intrinsic value May 21st 2020

The assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Sharps Compliance as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.0%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn’t be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For Sharps Compliance, There are three further aspects you should look at:

  1. Risks: Be aware that Sharps Compliance is showing 1 warning sign in our investment analysis , you should know about...

  2. Future Earnings: How does SMED's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NASDAQCM every day. If you want to find the calculation for other stocks just search here.

Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.